Although many risk factors could have causal association with endometrial cancer, they are
also prone to residual confounding or other biases which could lead to over‐or …

Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence
Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted …

Each year, endometrial cancer develops in about 142 000 women worldwide, and an
estimated 42 000 women die from this cancer. The typical age-incidence curve for …

Several studies have suggested that diabetes mellitus may alter the risk of developing a
variety of cancers, and the associations are biologically plausible. To learn more about the …

Aims/hypothesis Diabetes has been associated with a statistically significantly increased risk
of endometrial cancer in most, but not all studies. To provide a quantitative assessment of …

OBJECTIVE: Endometrial cancer is the most common gynecologic malignancy in the United
States. The mean age at diagnosis is 61 years; however, 5–30% of women are aged …

Objective To systematically review the literature on the association between obesity and
endometrial hyperplasia or cancer in premenopausal women. Data Sources We searched …

BACKGROUND Most contraceptive methods present benefits beyond contraception;
however, despite a large body of evidence, many healthcare professionals (HCPs), users …

Endometrial cancer is the commonest gynaecological cancer mostly affecting women in the
post-menopausal age group. Rates vary worldwide and are highest in white women in …

ContextA family history of certain cancers is associated with an increased risk of developing
cancer. Both cancer screening and genetic services referral decisions are often based on …